Thorough QT study with ponesimod, a selective S1P1 receptor modulator
Latest Information Update: 16 Feb 2016
At a glance
- Drugs Ponesimod (Primary) ; Moxifloxacin
- Indications Graft-versus-host disease; Immunological disorders; Multiple sclerosis; Plaque psoriasis
- Focus Adverse reactions
- 20 Sep 2013 New trial record
- 31 Aug 2013 Results presented at the 11th Congress of the European Association for Clinical Pharmacology and Therapeutics.